FDA Drug Application (018027) for LITHOBID by ANI PHARMS INC

Back to FDA Applications sponsored by ANI PHARMS INC

Application Number018027
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLITHOBID
Active IngredientLITHIUM CARBONATE

Active IngredientCount
List of drugs with Active Ingredient LITHIUM CARBONATE7


Back to FDA Applications sponsored by ANI PHARMS INC